Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIMEC Atlantis Energy Regulatory News (SAE)

  • There is currently no data for SAE

MeyGen Operations Update

10 Jul 2017 07:00

RNS Number : 5196K
Atlantis Resources Limited
10 July 2017
 

Monday 10 July 2017

 

Atlantis Resources Limited

("Atlantis" or the "Company")

 

MeyGen Operations Update

 

Atlantis, a global leader in the marine power generation sector, provides an operational update for Phase 1A of the MeyGen project in the Pentland Firth following the recent successful reinstallation, reconnection and commencement of operation of two of the four turbines.

 

As previously announced, the three Andritz Hydro Hammerfest (AHH) turbines were recovered earlier this year following an initial period of operations to enable AHH to implement system enhancements derived from the lessons learned during installation and subsea commissioning. Following this programme of turbine improvements, two of the three AHH turbines were successfully reinstalled and reconnected, and have recommenced power generation to the grid.

 

The third AHH turbine is due to be reinstalled during the next workable neap tide which is in August, together with the Atlantis AR1500 turbine. The Atlantis turbine was also retrieved in the spring of this year to assess the effects of a prolonged grid connection outage which was caused by damage to part of the onshore power distribution network near the MeyGen site. The cable damage has since been repaired and the site's grid export capacity has been restored. After assessment of the turbine it was decided that one of the components of the turbine's pitching system should be replaced and upgraded as a result of the exposure to an unexpectedly long idle cycle.

 

As commissioning and autonomous operation had been well progressed following initial installation, it is expected that full power will be achieved from each turbine soon after redeployment. The turbines will then enter into their final contractual performance and autonomous reliability tests after which they will be signed off for commencement of long term operations.

 

It is expected that MeyGen Phase 1A will be operating autonomously at full 6 MW capacity by the end of Q3.

 

Tim Cornelius, Chief Executive of Atlantis, said:

 

"We are delighted that we have conducted another successful installation campaign and that we will soon have the array operating autonomously, generating predictable revenue. Both turbines have already operated at or close to full power since redeployment.

 

"Prior to retrieval of the turbines in the spring we had already achieved significant autonomous operation at full output and the power performance of both turbine types showed improvements over the contractual output guarantees. We expect this to put the project on track to achieve capacity factors significantly in excess of 40%.

 

"We expect to be generating at full output from the end of Q3 and for the suppliers to fully hand over the turbines to the project operating team shortly thereafter."

 

  

Enquiries:

 

Atlantis Resources

via FTI Consulting

Tim Cornelius, Chief Executive Officer

Simon Counsell, Chief Financial Officer

 

 

 

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

Adrian Trimmings

Jock Maxwell Macdonald

 

 

 

Macquarie Capital (Europe) Limited (Joint Broker)

Raj Khatri

Nick Stamp

+44 (0)20 3037 2000

 

 

FTI Consulting

+44 (0)20 3727 1000

Ben Brewerton

Alex Beagley

James Styles

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDOKCDDFBKDKOK
Date   Source Headline
7th Oct 202111:05 amRNSSecond Price Monitoring Extn
7th Oct 202111:00 amRNSPrice Monitoring Extension
7th Oct 20219:00 amRNSPrice Monitoring Extension
7th Oct 20217:16 amRNSDuplicate - SAE Uskmouth permit update
7th Oct 20217:00 amRNSSAE Uskmouth permit update
7th Oct 20217:00 amRNSOperational Update
6th Oct 20219:23 amRNSBlock listing Interim Review
6th Oct 20217:00 amRNSHolding(s) in Company
29th Sep 20219:06 amRNSSecond Price Monitoring Extn
29th Sep 20219:00 amRNSPrice Monitoring Extension
29th Sep 20217:00 amRNSResults of Placing
28th Sep 20215:22 pmRNSPlacing announcement
28th Sep 20215:19 pmRNSInterim Results (unaudited)
1st Sep 20217:00 amRNSTotal Voting Rights
19th Aug 20218:13 amRNSResult of AGM
18th Aug 20217:00 amRNSShare Issuance
28th Jul 20217:00 amRNSShare Issuance
23rd Jul 20212:05 pmRNSSecond Price Monitoring Extn
23rd Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jul 20219:05 amRNSSecond Price Monitoring Extn
23rd Jul 20219:00 amRNSPrice Monitoring Extension
23rd Jul 20217:00 amRNSCompany update
21st Jul 20217:00 amRNSDirectorate Change
16th Jul 20217:00 amRNSNotice of AGM
30th Jun 202111:05 amRNSSecond Price Monitoring Extn
30th Jun 202111:00 amRNSPrice Monitoring Extension
30th Jun 20217:00 amRNSFinal Results Announcement
21st Jun 202111:05 amRNSSecond Price Monitoring Extn
21st Jun 202111:00 amRNSPrice Monitoring Extension
9th Jun 20217:00 amRNSCompany Update
3rd Jun 20217:00 amRNSSAE Partners with Remediiate
1st Jun 20217:00 amRNSTotal Voting Rights
25th May 20217:00 amRNSIssue of Equity
24th May 202111:06 amRNSSecond Price Monitoring Extn
24th May 202111:00 amRNSPrice Monitoring Extension
24th May 20219:00 amRNSPrice Monitoring Extension
24th May 20217:00 amRNSSAE achieves another tidal milestone in Japan
24th May 20217:00 amRNSUskmouth Planning Update
20th May 20214:41 pmRNSSecond Price Monitoring Extn
20th May 20214:35 pmRNSPrice Monitoring Extension
18th May 202111:05 amRNSSecond Price Monitoring Extn
18th May 202111:00 amRNSPrice Monitoring Extension
18th May 20217:00 amRNSCompany Update
21st Apr 20217:00 amRNSHolding(s) in Company
15th Apr 20217:00 amRNSInvestment under Share Placement Agreement
8th Apr 20212:05 pmRNSSecond Price Monitoring Extn
8th Apr 20212:00 pmRNSPrice Monitoring Extension
7th Apr 202111:05 amRNSSecond Price Monitoring Extn
7th Apr 202111:00 amRNSPrice Monitoring Extension
7th Apr 20219:10 amRNSOperational update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.